COLLABORATIVE LICENSE, EXCLUSIVE MANUFACTURE ANDCollaborative License, Exclusive Manufacture and Global Supply Agreement • May 17th, 2019 • Egalet Corp • Pharmaceutical preparations • New Jersey
This COLLABORATIVE LICENSE, EXCLUSIVE MANUFACTURE AND GLOBAL SUPPLY AGREEMENT (Agreement"), dated August 1, 2008 (the "Signature Date") and deemed effective as of November 1, 2008 (the "Launch Date"), is by and between:
AMENDED AND RESTATED NANO-REFORMULATED COMPOUND LICENSE AGREEMENTNano-Reformulated Compound License Agreement • May 17th, 2019 • Egalet Corp • Pharmaceutical preparations • Delaware
This Amended and Restated Nano-Reformulated Compound License Agreement (this “Agreement”), dated October 30, 2018 (the “Agreement Date”), is made by and among iCeutica Inc., a Delaware corporation (“iCeutica Inc.”), its wholly-owned subsidiary iCeutica Pty Ltd., an Australian corporation (together, “iCeutica”), Iroko Pharmaceuticals, LLC, a Delaware limited liability company (“Iroko LLC”) and Iroko Properties Inc., a British Virgin Islands company (“Properties BVI” and together with Iroko LLC, “Iroko”). iCeutica and Iroko are individually referred to herein as a “Party” and collectively referred to herein as the “Parties.”
Manufacturing Services Agreement May 29, 2009Manufacturing Services Agreement • May 17th, 2019 • Egalet Corp • Pharmaceutical preparations • Delaware
THIS AGREEMENT WITNESSES THAT in consideration of the rights conferred and the obligations assumed herein, and for other good and valuable consideration (the receipt and sufficiency of which are acknowledged by each party), and intending to be legally bound the parties agree as follows:
EGALET CORPORATION Option AgreementOption Agreement • May 17th, 2019 • Egalet Corp • Pharmaceutical preparations • Delaware
This Option Agreement (this "Agreement") is made and entered into as of __________, 20__ (the “Grant Date”) by and between Egalet Corporation, a Delaware corporation (the "Company"), and ________________ (the "Participant").
COMMERCIAL SUPPLY AGREEMENTCommercial Supply Agreement • May 17th, 2019 • Egalet Corp • Pharmaceutical preparations • Pennsylvania
This Commercial Supply Agreement ("Agreement") is entered into with effect as of 01 October 2018 (the “Effective Date”), by and between Iroko Pharmaceuticals, LLC a Delaware limited liability company, with a place of business at One Kew Place, 150 Rouse Boulevard, Philadelphia, Pennsylvania 19112 USA ("Iroko"), and Catalent CTS, LLC with a place of business at 10245 Hickman Mills Drive, Kansas City, Missouri 64137 USA ("Catalent").
